BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Geojit Research Report
We remain optimistic about Granules India Ltd.'s long-term profitability and growth prospects owing to new product launches, a focus on backward integration, and increased market share in existing geographies.
However, delayed launches of some of the molecules are likely to impact revenue.
Therefore, we downgrade our rating to 'Accumulate' with a target price of Rs 464 based on 16 times FY26E earnings per share.
Click on the attachment to read the full report:
Also Read: India Strategy, Economy - Is The GDP Blitzkrieg A Statistical Exaggeration? Systematix Analysis
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
NTPC Green Energy IPO - Should You Subscribe? Read Geojit's Analysis
Nov 18, 2024
Bata India Q2 Results Review - Sectoral Headwinds Put Pressure On The Earnings; Upgrade To 'Buy': IDBI Capital
Nov 11, 2024
Cummins Q2 Results Review - Healthy Performance; Sanguine Demand Momentum To Continue: IDBI Capital
Nov 08, 2024
Cyient DLM Q2 Results - Motilal Oswal Retains 'Buy' Rating On The Stock; Here's Why
Oct 22, 2024
POPULAR